37494-10-3

Basic information

• Product Name: 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone
• Synonyms: 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone
• CAS NO: 37494-10-3
• Molecular Weight: 170.252
• Mol File: 37494-10-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone(37494-10-3)
• EPA Substance Registry System: 6-hydroxy-2,2,5,5-tetramethyl-1-cyclohexanone(37494-10-3)

Safety Data

• Hazardous Substances Data: 37494-10-3(Hazardous Substances Data)

Upstream product

• 4916-85-2 2,2,5,5-tetramethylhexanedioic acid 
• 4388-88-9 pivalil 

Downstream Products

• 37490-68-9 (2,2,5,5-Tetramethylcyclohexanon)-azin 
• 37490-64-5 1-Brom-2-chlor-3,3,6,6-tetramethylcyclohexen 
• 37490-75-8 3,3,6,6-Tetramethyl-1-chlorcyclohexen 
• 15189-14-7 2,2,5,5-tetramethylcyclohexanone 
• 50740-76-6 3,3,6,6-tetramethyl-cyclohexene 
• 2223-52-1 1,1,4,4-Tetramethylcyclohexan 
• 187401-91-8 methyl 4-[4-oxo-4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)butanoyl]benzoate 
• 187401-95-2 methyl 4-[3-oxo-3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)propanoyl]benzoate 
• 261162-96-3 methyl 4-[5-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1H-3-pyrazolyl]benzoate 
• 261162-87-2 methyl 4-[5-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1H-2-pyrrolyl]benzoate 
• 261162-97-4 methyl 4-[4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1H-2-imidazolyl]benzoate 
• 261162-98-5 methyl 4-[4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1,3-thiazol-2-yl]benzoate 
• 187400-18-6 ER-34617 
• 261162-86-1 ethyl 4-{[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)carboyl]amino}benzoate 

Relevant articles and documents

Syntheses and structure-activity relationships of 5,6,7,8-tetrahydro- 5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor α agonistic activity

In the course of our studies on retinoic acid receptor (RAR) agonists, we have designed and synthesized a series of quinoxaline derivatives. One of them, 4-[5-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1H-2- pyrrolyl]benzoic acid (3a), which